Reproductive Health Program in Patients With Cancer

Korábbi kezelés

• Patients who have initiated chemotherapy, radiation therapy or endocrine therapy prior to registration to this study
• Prior hysterectomy, bilateral oophorectomy or sterilization of any method

• Female patients presenting with initial diagnosis of any type of cancer, including patients with ductal carcinoma in situ (DCIS)
• Pre-menopausal patients within the reproductive age range of 15-55 years; pre-menopausal is defined as females meeting the following criteria:
  • Patients not currently on hormonal contraception with the presence of menses in the past 6 months
  • If no menstruation in the past 6 months, without hormonal manipulation, then confirmed follicle-stimulating hormone (FSH) < 23mlU/mL
  • If age < 47 years and on hormonal contraception, then patient will be eligible regardless of menstrual history
  • If age ≥ 47 years and on hormonal contraception, then FSH confirmed < 23mIU/mL
• Pregnant women are eligible to participate in this study
• Patients must have the cognitive ability to participate in the study